Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New practices suggested for HIV testing

This article was originally published in Clinica

Executive Summary

Current HIV testing practices, which typically measure HIV-1 levels in the blood, might not accurately indicate how much virus is in the semen, a new study has shown. Testing HIV levels in semen, as well as targeting treatments to sites where the seminal virus is produced, could allow doctors to monitor viral activity in HIV patients better and also help reduce HIV transmission, the researchers suggested.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT082927

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel